Predicting hospital length of stay at admission using global and country-specific competing risk analysis of structural, patient, and nutrition-related data from utritionDay 2007-2... by Kiss, N, Hiesmayr, M, Sulz, I, Bauer, P, Heinze, G, Mouhieddine, M, Schuh, C, Tarantino, S, Simon, J

Cost-effectiveness of Positive Memory Training (PoMeT) for the treatment of depression in schizophrenia by Simon, J, Kiss, N, Korrelboom, K, Kingdon, D, Wykes, T, Phiri, P, van der Gaag, M, Baksh, MF, Steel, C

Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial. by Barnes, T, Leeson, V, Paton, C, Costelloe, C, Simon, J, Kiss, N, Osborn, D, Killaspy, H, Craig, T, Lewis, S, Keown, P, Ismail, S, Crawford, M, Baldwin, D, Lewis, G, Geddes, J, Kumar, M, Pathak, R, Taylor, S